Moreover, patients with lung cancer have exhibited lower levels of peripheral blood HOTAIRM1 than healthy controls, indicating that HOTAIRM1 might be an ideal biomarker for diagnosing lung cancer (89). Here, HOTAIRM1 is linked to lung carcinoma.